Inflammation of breast tissue — typically bacterial in lactating women; rule out inflammatory breast cancer in non-lactating cases.
Also known as: mastitis, lactational mastitis, puerperal mastitis, non-lactational mastitis, periductal mastitis, breast abscess
Overview
Inflammation of breast tissue, with or without infection. Lactational (puerperal) mastitis occurs in breastfeeding women, usually due to milk stasis ± bacterial superinfection. Non-lactational mastitis includes periductal mastitis and idiopathic granulomatous mastitis.
Epidemiology
Occurs in ~10% of breastfeeding women, most commonly in the first 6 weeks postpartum. Non-lactational mastitis is less common, more often in women aged 30-60, often associated with smoking.
Try two board-style Mastitis questions
Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.
Question 1ReproductiveMedium
A 28-year-old woman presents 3 weeks postpartum with 2 days of pain, warmth, and redness in the upper outer left breast. She is exclusively breastfeeding a healthy infant and reports a cracked left nipple, fever to 38.7°C, chills, and body aches. On exam she has a tender, firm, wedge-shaped area of erythema and induration without fluctuance; the overlying skin is warm. There is no MRSA risk in the community. She is advised to continue breastfeeding and ensure effective milk removal. Which of the following is the most appropriate empiric antibiotic?
AOral dicloxacillin as initial therapy
BOral amoxicillin-clavulanate as therapy
COral azithromycin as initial therapy
DOral penicillin VK as initial therapy
Reveal answer & full explanation
Correct answer: A — Oral dicloxacillin as initial therapy
AOral dicloxacillin as initial therapy✓
BOral amoxicillin-clavulanate as therapy
COral azithromycin as initial therapy
DOral penicillin VK as initial therapy
Why Oral dicloxacillin as initial therapy is correct
This is classic lactational mastitis: a febrile, systemically ill breastfeeding woman within the first 6 weeks postpartum with a focal, wedge-shaped, tender erythematous segment and a cracked nipple as the bacterial entry point.
Staphylococcus aureus is the predominant pathogen, so an anti-staphylococcal agent such as dicloxacillin (500 mg PO QID for 10-14 days) is the guideline-recommended empiric choice when symptoms are severe or persist beyond 24 hours and there is no MRSA risk.
Continued breastfeeding with effective milk removal is therapeutic and essential; it relieves the milk stasis driving the infection and is safe for the infant.
Why the others are wrong
Oral amoxicillin-clavulanate as therapy - the added anaerobic coverage is reserved for non-lactational periductal mastitis, not first-line lactational mastitis where S. aureus predominates.
Oral azithromycin as initial therapy - a macrolide with unreliable antistaphylococcal activity and low serum levels, so it undertreats the S. aureus driving a systemically febrile mastitis.
Oral penicillin VK as initial therapy - hydrolyzed by staphylococcal penicillinase, so it fails against the beta-lactamase-producing S. aureus that causes most lactational mastitis.
Question 2ReproductiveMedium
A 28-year-old woman who is 3 weeks postpartum presents with 2 days of pain, warmth, and redness over the upper outer quadrant of her right breast, along with fever and body aches. She is exclusively breastfeeding her first child. Examination reveals a tender, wedge-shaped area of erythema and induration; her temperature is 38.7°C. Which of the following is the strongest risk factor for this condition?
AUse of a nipple shield device
BPrimiparity with her first infant
CNipple trauma from poor latch
DLong history of cigarette smoking
Reveal answer & full explanation
Correct answer: C — Nipple trauma from poor latch
AUse of a nipple shield device
BPrimiparity with her first infant
CNipple trauma from poor latch✓
DLong history of cigarette smoking
Why Nipple trauma from poor latch is correct
This patient has classic lactational (puerperal) mastitis: a breastfeeding woman in the first 6 weeks postpartum with a unilateral, wedge-shaped area of erythema, induration, and flu-like systemic symptoms.
The strongest, most direct risk factors for lactational mastitis are nipple trauma (cracked or fissured nipples from poor latch) and milk stasis from infrequent feeding or engorgement. Nipple fissures provide a portal of entry for Staphylococcus aureus, while stagnant milk serves as a culture medium for bacterial proliferation.
Why the others are wrong
Use of a nipple shield device — a shield can impair milk transfer and contribute to stasis, but it is a minor and inconsistently reported contributor compared with the cracked, fissured nipples that give Staphylococcus aureus a portal of entry.
Primiparity with her first infant — first-time mothers do have somewhat higher rates, largely because latch difficulty and nipple damage are more common in them, so parity is an upstream marker rather than the strongest direct risk factor.
Long history of cigarette smoking — smoking is the key risk factor for non-lactational periductal mastitis, not for lactational mastitis in a postpartum breastfeeding woman.
🔒 Free preview limit reached
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Mastitis outline — plus all 514 diagnoses, 6,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Lactational: cracked or sore nipples, infrequent or skipped feedings, poor latch, breast engorgement, oversupply, prior mastitis, maternal stress and fatigue
Both: Staphylococcus aureus (including MRSA) is the most common organism
Pathophysiology
Milk stasis creates a culture medium for bacterial proliferation; pathogens enter via nipple fissures. Inflammatory cascade produces local pain, warmth, and systemic symptoms. Untreated infection can progress to abscess. Periductal mastitis arises from squamous metaplasia and keratin plugging of subareolar ducts.
Clinical presentation
Symptoms
Unilateral breast pain, warmth, erythema
Fever, chills, malaise, myalgias (flu-like)
Hard, tender wedge-shaped area
Cracked or fissured nipple
Signs / physical exam
Erythematous, warm, indurated, tender quadrant or segment
Fever >38.5°C, tachycardia
Lymphadenopathy (axillary)
Fluctuance suggests abscess
Inflammatory breast cancer hallmark: erythema, peau d'orange WITHOUT fever or rapid antibiotic response
Differential diagnosis
Inflammatory breast cancer — Non-lactating woman, no fever, peau d'orange, no improvement with antibiotics — MANDATORY biopsy if not resolving in 1-2 weeks
Engorgement — Bilateral diffuse breast fullness without focal erythema; relieved by feeding/pumping
Plugged duct — Localized tender lump without systemic symptoms; resolves with massage and feeding
Breast abscess — Fluctuant mass; requires drainage
Idiopathic granulomatous mastitis — Painful firm mass with sinus tracts; biopsy with granulomas; mimics cancer
Clinical diagnosis in lactational mastitis with classic features
Milk culture and sensitivity if no improvement at 48-72 hours, severe symptoms, or recurrence
CBC (leukocytosis common)
Blood cultures if septic
Imaging
Ultrasound if abscess suspected (fluctuance, no improvement after 48-72 h antibiotics, palpable mass)
Mammography ± biopsy for non-lactational mastitis or any mastitis not resolving with appropriate antibiotic therapy — rule out inflammatory breast cancer
Diagnostic algorithm
Feature
Lactational Mastitis
Inflammatory Breast Cancer
Setting
Postpartum breastfeeding woman
Non-lactating, often older
Onset
Hours-days
Weeks
Fever
Common
Absent
Skin
Localized erythema (wedge)
Diffuse peau d'orange
Response to antibiotics
Improvement in 48-72 h
No improvement
Treatment
Continue feeding + antibiotics
Biopsy → neoadjuvant chemo + surgery + RT
Critical action
Reassess at 48-72 h
Biopsy if not resolving in 1-2 weeks of antibiotics
Distinguishing lactational mastitis from inflammatory breast cancer — failure to improve is the red flag.
Treatment
First-line
Continue breastfeeding or pumping — emptying the breast is essential; safe for the infant
Effective milk removal: frequent breastfeeding, start on affected side, varied positions, gentle hand expression
Warm compresses before feeding, cool compresses after
Analgesia: ibuprofen, acetaminophen
Empiric antibiotics if symptoms severe, persistent >24 h, or systemic signs:
• Dicloxacillin 500 mg PO QID × 10-14 days OR
• Cephalexin 500 mg PO QID × 10-14 days
• If MRSA risk or treatment failure: clindamycin 300 mg PO QID, OR trimethoprim-sulfamethoxazole DS BID (avoid in mothers of infants <2 months or with G6PD)
Hydration, rest, lactation consultant referral
Breast abscess
Ultrasound-guided needle aspiration (first-line for many abscesses; may need to repeat)
Surgical incision and drainage for large or multiloculated abscesses
Continue antibiotics
Continue breastfeeding/pumping (unless drainage site near nipple; pump that side and discard until healed)
Non-lactational mastitis
Antibiotics with anaerobic coverage (amoxicillin-clavulanate) — periductal mastitis often involves anaerobes
Smoking cessation
Image and biopsy promptly if not resolving — exclude inflammatory breast cancer
Idiopathic granulomatous mastitis: biopsy first; treatment ranges from observation to corticosteroids or methotrexate
Complications
Breast abscess
Sepsis (rare)
Recurrent mastitis
Premature weaning
Inflammatory breast cancer misdiagnosed as mastitis — delayed diagnosis
Galactocele
Chronic periductal mastitis with fistula formation
PANCE pearls
Continue breastfeeding through mastitis — it's both safe and therapeutic; milk emptying is essential treatment.
Inflammatory breast cancer mimics mastitis. ANY mastitis in a non-lactating woman, or any 'mastitis' not improving with antibiotics in 1-2 weeks, warrants biopsy.
MRSA is increasingly common in breast abscesses — empiric coverage with clindamycin or TMP-SMX if local prevalence high.
Periductal mastitis (subareolar) in smokers can produce chronic fistulas requiring excision of involved ducts.
Ultrasound-guided aspiration often replaces surgical I&D for breast abscesses, especially in lactating women.
References
ABM 2022 — Academy of Breastfeeding Medicine Clinical Protocol #36: The Mastitis Spectrum, Revised 2022 (Mitchell et al., Breastfeed Med 2022)
ACOG CO 821 — ACOG Committee Opinion 821: Benign Breast Conditions
WHO 2000 — Mastitis: Causes and Management (WHO/FCH/CAH/00.13)
Practice Reproductive questions on FirstPassPA
Turn this outline into retention. 6,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.